Avian influenza: recent epidemiology, travel-related risk, and management
- PMID: 25475382
- PMCID: PMC7088727
- DOI: 10.1007/s11908-014-0456-3
Avian influenza: recent epidemiology, travel-related risk, and management
Abstract
H5N1 influenza continues to smolder in Southeast Asia over the past 5 years, but the emergence of H7N9 in China in 2012 raised concerns for a new avian influenza threat. In contrast with H5N1 with over 650 confirmed cases over 11 years, H7N9 has infected over 450 persons within 2 years. The case fatality rate for H7N9 (35 %) is lower than for H5N1 (60 %) or H10N8 (67 %) but is comparable to that for the Middle East respiratory syndrome coronavirus (MERS CoV), another emerging zoonosis with travel-associated importations. Exposure to poultry and fomites are considered the likely sources of infection for H7N9, H5N1, and H10N8, with limited human-to-human transmission in close contacts. Most cases have occurred in local populations of affected countries, and travel-related risk can be mitigated by avoiding exposure. Vaccines, antivirals, and other therapeutics remain in development stage or of modest benefit for dangerous infections carrying high morbidity and mortality.
References
-
- H5N1 avian influenza: timeline of major events 13 December 2011 http://www.who.int/influenza/human_animal_interface/avian_influenza/H5N1.... Accessed 2 July 2014.
-
- World Health Organisation. Influenza monthly risk assessment. Available at http://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en/. Accessed 2 July 2014.
-
- WHO risk assessment of human infection with avian influenza A(H7N9) virus http://www.who.int/influenza/human_animal_interface/influenza_h7n9/14022.... Accessed 2 July 2014. - PubMed
-
- Isolation of avian influenza A(H5N1) viruses from humans—Hong Kong, May-December 1997. MMWR. 1997;46(50):1204–1207. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
